Perioperative posterior cervical muscle plane block decreased numerical pain rating scores vs anesthesia alone in posterior cervical spine surgery.

The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

“It’s almost like you can feel that the land is in pain, and you are carrying that pain in your body as well.” The destruction of parts of Ritidian Point weigh heavily on her and other Chamorro.

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

This new drug is a non-opioid analgesic, the first of its kind, designed to treat moderate to severe acute pain in adults. Journavx works by targeting a pain-signaling pathway involving sodium ...

Common reasons for back pain include muscle strain, disk damage, and some chronic conditions, such as fractures due to osteoporosis. Potential treatments include heat therapy, acupuncture ...

This new drug is a non-opioid analgesic, the first of its kind, designed to treat moderate to severe acute pain in adults. Journavx works by targeting a pain-signaling pathway involving sodium ...